By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Agios Pharmaceuticals 

38 Sidney Street
2nd Floor
Cambridge  Massachusetts  02139-4169  U.S.A.
Phone: 617-649-8600 Fax: n/a


SEARCH JOBS








Company News
Agios Pharmaceuticals (AGIO) Announces Early Phase 1 Data Showing Clinical Activity Of AG-120 As A Single Agent In Advanced Acute Myeloid Leukemia (AML) 11/18/2014 4:43:48 PM
Citi: Agios Pharmaceuticals (AGIO)’s Experimental Cancer Drug Could Provide Major Upside 11/10/2014 12:58:54 PM
Agios Pharmaceuticals (AGIO) Reports Third Quarter 2014 Financial Results 11/7/2014 8:47:52 AM
Agios Pharmaceuticals (AGIO) To Present Clinical And Preclinical Data At The 2014 American Society of Hematology Annual Meeting 11/6/2014 10:42:19 AM
Agios Pharmaceuticals (AGIO) To Webcast Conference Call Of Third Quarter 2014 Financial Results On November 7, 2014 10/27/2014 9:59:42 AM
Agios Pharmaceuticals (AGIO) Announces Initiation Of A Phase 1/2 Clinical Trial Of AG-221 In Patients With Advanced Solid Tumors With An IDH2 Mutation 10/21/2014 7:42:29 AM
Agios Pharmaceuticals (AGIO) Smart Buy Ahead Of Cancer Data: Citi 10/16/2014 2:20:13 PM
Agios Pharmaceuticals (AGIO) Announces Initiation Of Four Expansion Cohorts In Phase 1 Study Of AG-221 10/15/2014 7:43:47 AM
Agios Pharmaceuticals (AGIO) To Webcast R&D Day On October 15, 2014 10/6/2014 7:39:24 AM
Agios Pharmaceuticals (AGIO) To Present Clinical Data From AG-120 Ongoing Phase 1 Study In Hematologic Malignancies At EORTC-NCI-American Association for Cancer Research 2014 9/26/2014 8:22:08 AM
123456789
//-->